US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
21.11.2025
Food and Drug Administration said on Friday that it will convene a panel of experts on January 22, 2026, to review an request by Swedish Match USA, a unit of Philip Morris International, to market its ZYN nicotine pouches as lower-risk alternatives to cigarettes. The advisory committee will examine modified-risk applications for 20 ZYN products, each sold in 3-mg and 6-mg strengths.